FindTrial
Sign In

Outcome of Suprachoroidal Hemorrhage Associated with Vitrectomy Surgery

Outcome of Suprachoroidal Hemorrhage Associated with Vitrectomy Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055578
Enrollment
Unknown
Registered
2022-01-14
Start date
2017-07-01
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

suprachoroidal hemorrhage

Interventions

Pars plana vitrectomy group:None

Sponsors

Zhongda Hospital, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patients were treated in Zhongda Hospital, Southeast University for pars plana vitrectomy; 2. The intraoperative choroidal bulge or postoperative eye examination suggesting SCH; 3. At least 3 months of follow-up.

Exclusion criteria

Exclusion criteria: 1. Preoperative suprachoroidal haemorrhage; 2. History of ocular trauma; 3. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
surgery method;eye fundus;—

Countries

China

Contacts

Public ContactLuan Jie

Zhongda Hospital, Southeast University

luanqiu10@163.com+86 13952008836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026